HomeBristol Myers Squibb

Bristol Myers Squibb

Bristol Myers to Acquire Karuna Therapeutics for $14 Billion

Bristol Myers to Acquire Karuna Therapeutics for $14 Billion

December 22, 2023

Bmy Stock Rises as Trials for MS Drug Zeposia Record Serologic Response to COVID Vaccines Among Recipients

Bmy Stock Rises as Trials for MS Drug Zeposia Record Serologic Response to COVID Vaccines Among Recipients

October 26, 2022

Bristol Myers’ Q3 Revenues Decreased Due to Generic Revlimid Competition and Currency Issues

Bristol Myers’ Q3 Revenues Decreased Due to Generic Revlimid Competition and Currency Issues

October 26, 2022

BMY Stock and SPPI Increase on FDA Approvals, CLVS Increases by 15%, and Twtr Decreases on the Musk Saga

BMY Stock and SPPI Increase on FDA Approvals, CLVS Increases by 15%, and Twtr Decreases on the Musk Saga

September 12, 2022

Bristol-Myers Slumps 5% Largest Drop In 2 Years Following Mid-Stage Data for Blood Thinner

Bristol-Myers Slumps 5% Largest Drop In 2 Years Following Mid-Stage Data for Blood Thinner

August 29, 2022